Anti-TNF therapy
- 1 August 2011
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Rheumatology
- Vol. 25 (4), 549-567
- https://doi.org/10.1016/j.berh.2011.10.004
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Blockade of TNF-α rapidly inhibits pain responses in the central nervous systemProceedings of the National Academy of Sciences, 2011
- No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2010
- Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safetyRheumatology, 2010
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology, 2010
- Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics registerArthritis Care & Research, 2010
- Biosimilar therapeutics--what do we need to consider?NDT Plus, 2009
- The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor expression in the synoviumAnnals Of The Rheumatic Diseases, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite studyAnnals Of The Rheumatic Diseases, 2007
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988